Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed 2021-12-03 Acc 0001209191-21-067893

Director bought 882 shares at an average $2.72 ($2,402)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Jones James Director	2021-11-01	Purchase	+42	$2.67	$112	18,102	D
Jones James Director	2021-11-02	Purchase	+42	$2.63	$110	18,144	D
Jones James Director	2021-11-03	Purchase	+42	$2.71	$114	18,186	D
Jones James Director	2021-11-04	Purchase	+42	$2.73	$115	18,228	D
Jones James Director	2021-11-05	Purchase	+42	$2.71	$114	18,270	D
Jones James Director	2021-11-08	Purchase	+42	$2.95	$124	18,312	D
Jones James Director	2021-11-09	Purchase	+42	$3.21	$135	18,354	D
Jones James Director	2021-11-10	Purchase	+42	$2.94	$123	18,396	D
Jones James Director	2021-11-11	Purchase	+42	$2.83	$119	18,438	D
Jones James Director	2021-11-12	Purchase	+42	$2.67	$112	18,480	D
Jones James Director	2021-11-15	Purchase	+42	$2.71	$114	18,522	D
Jones James Director	2021-11-16	Purchase	+42	$2.66	$112	18,564	D
Jones James Director	2021-11-17	Purchase	+42	$2.58	$108	18,606	D
Jones James Director	2021-11-18	Purchase	+42	$2.58	$108	18,648	D
Jones James Director	2021-11-19	Purchase	+42	$2.55	$107	18,690	D
Jones James Director	2021-11-22	Purchase	+42	$2.35	$99	18,732	D
Jones James Director	2021-11-23	Purchase	+42	$2.29	$96	18,774	D
Jones James Director	2021-11-24	Purchase	+42	$2.31	$97	18,816	D
Jones James Director	2021-11-26	Purchase	+42	$2.26	$95	18,858	D
Jones James Director	2021-11-29	Purchase	+42	$2.23	$94	18,900	D
Jones James Director	2021-11-30	Purchase	+42	$4.61	$194	18,942	D
Open-market purchases · 882 sh · avg $2.72 · $2,402